17762 | $CMPI On Alert! Checkmate Pharmaceuticals to | jmtimz | 06/08/2021 8:33:06 AM |
19587 | $CBDD A key driver of the Company's year-to-date | Lets Roll | 12/21/2021 10:01:59 AM |
915 | $SING Must see video of the CEO of SinglePoint, | budfoxfun | 11/09/2015 8:15:25 AM |
914 | CTIX | budfoxfun | 11/09/2015 8:15:10 AM |
913 | AMRN | budfoxfun | 11/09/2015 8:14:55 AM |
912 | TDEY | budfoxfun | 11/09/2015 8:14:39 AM |
911 | AVXL | budfoxfun | 11/09/2015 8:14:34 AM |
910 | GEQU | budfoxfun | 11/09/2015 8:14:18 AM |
909 | PXYN | budfoxfun | 11/09/2015 8:14:07 AM |
908 | MJNA | budfoxfun | 11/09/2015 8:13:59 AM |
907 | OWOO | budfoxfun | 11/09/2015 8:13:47 AM |
906 | NWAV | budfoxfun | 11/09/2015 8:13:41 AM |
905 | HDSI | budfoxfun | 11/09/2015 8:13:31 AM |
904 | BRWC | budfoxfun | 11/09/2015 8:13:23 AM |
903 | TWTR | budfoxfun | 11/09/2015 8:13:15 AM |
902 | AAPL | budfoxfun | 11/09/2015 8:13:10 AM |
901 | GOOGL | budfoxfun | 11/09/2015 8:13:03 AM |
900 | GLD | budfoxfun | 11/09/2015 8:12:58 AM |
899 | NFLX | budfoxfun | 11/09/2015 8:12:53 AM |
898 | VIRA | budfoxfun | 11/09/2015 8:12:44 AM |
897 | TBEV | budfoxfun | 11/09/2015 8:12:37 AM |
896 | PUGE | budfoxfun | 11/09/2015 8:12:29 AM |
895 | DSUS | budfoxfun | 11/09/2015 8:12:21 AM |
894 | $UPPR | budfoxfun | 11/09/2015 8:12:12 AM |
893 | $SING An Ethical Entry to the Daily Sports | budfoxfun | 11/09/2015 8:12:05 AM |
892 | $SING Must see video of the CEO of SinglePoint, | budfoxfun | 11/09/2015 8:11:49 AM |
891 | PMCB | budfoxfun | 11/09/2015 8:11:41 AM |
890 | RXSF | budfoxfun | 11/09/2015 8:11:30 AM |
889 | UMAX | budfoxfun | 11/09/2015 8:11:22 AM |
888 | TRTC | budfoxfun | 11/09/2015 8:11:16 AM |
887 | SWHI | budfoxfun | 11/09/2015 8:11:08 AM |
886 | ALL | budfoxfun | 11/09/2015 8:11:02 AM |
885 | ENIP | budfoxfun | 11/09/2015 8:10:54 AM |
884 | WOGI | budfoxfun | 11/09/2015 8:10:46 AM |
883 | VPRO | budfoxfun | 11/09/2015 8:10:37 AM |
882 | GDSI | budfoxfun | 11/09/2015 8:10:32 AM |
881 | INMG | budfoxfun | 11/09/2015 8:10:25 AM |
880 | SING | budfoxfun | 11/09/2015 8:10:17 AM |
879 | TDEY | budfoxfun | 11/09/2015 8:10:12 AM |
878 | CAT | budfoxfun | 11/09/2015 8:10:07 AM |
877 | IBM | budfoxfun | 11/09/2015 8:10:01 AM |
876 | AAPL | budfoxfun | 11/09/2015 8:09:57 AM |
875 | FB | budfoxfun | 11/09/2015 8:09:52 AM |
874 | TWTR | budfoxfun | 11/09/2015 8:09:48 AM |
873 | $IGEX Put this one on your radar! Most recent | Lets Roll | 11/09/2015 7:48:33 AM |
872 | About Upper Street Marketing: Upper Street | budfoxfun | 11/08/2015 3:15:11 PM |
871 | LOS ANGELES, CA / ACCESSWIRE / November 6, 2015 / | budfoxfun | 11/08/2015 3:14:57 PM |
870 | $UPPR big news hitting the wires on Friday! | budfoxfun | 11/08/2015 3:14:35 PM |
869 | $UPPR Keep your eyes on this one! MarketWatch | Lets Roll | 11/08/2015 12:04:48 PM |
868 | $UPPR In order to position itself as a key player | budfoxfun | 11/07/2015 10:30:14 AM |
867 | November 6, 2015 / Upper Street Marketing (UPPR) | budfoxfun | 11/07/2015 8:53:54 AM |
866 | $UPPR on alert next week, check out the after | budfoxfun | 11/07/2015 8:53:31 AM |
Recent Articles
- Lantheus Earnings Call Scheduled for February Discussion
- Intermex Plans to Announce 2024 Financial Results Soon
- Earnings Call and Financial Results Update for AFCG
- Exciting New Development by LGI Homes: Esplanade Community
- Exciting Financial Update from The Vita Coco Company Ahead
- Innovative Collaboration Between Greenridge Exploration and Indigenous Communities
- Apollo Funds Expand Portfolio with Bold Production Acquisition
- Bannix Acquisition Corp. Expands Deadline for Business Combination
- KALA BIO Welcomes New Leadership Amid Ongoing Innovations
- PharmaTher Advances FDA Application for Ketamine Therapy
- Madrigal Pharmaceuticals Plans Fourth-Quarter Finances Release
- Inuvo Introduces Innovative IntentKey Platform for Marketers
- Exciting Share-Based Payments by Kalmar: What You Need to Know
- Conduent Insights: Year-End 2024 Financial Performance Review
- Aeries Technology's Leadership Shift: Paving the Path to Growth
- Catalyst Pharmaceuticals' Upcoming Financial Results Conference
- Icelandic Salmon Announces Q4 2024 Results Presentation Details
- Prima's New Chapter: A Fresh Era in Wellness and Beauty
- Arbe Robotics to Present Q4 and Full Year 2024 Results Soon
- Promising Breakthrough in HPV Treatment: INO-3107 Clinical Review
- Chronograph and Bipsync Forge Partnership to Enhance Investment Insights
- Discover the Leading Consulting Firms to Work For in 2025
- Leadership Changes at Planet Fitness to Accelerate Growth Plans
- Terrain Biosciences Pioneers Rapid RNA Development Solutions
- Clearsense Unveils Rebranding and New Headquarters in Nashville
- Actinogen's Exciting Advances with Xanamem Unveiled in Study
- Empowering Women Entrepreneurs: Enthuse Foundation and Amazon Unite
- TriNetX and Fujitsu Team Up to Transform Healthcare in Japan
- Revolutionizing Secure Remote Access for Organizations Globally
- Cybersecurity and AI Governance Shape Audit Committee Focus
- Global Telesat Gains New Contract for Advanced Tracking Services
- INDIAWOOD 2025: A Showcase of Innovation in Woodworking
- Unison Introduces PRISM 7.6: Revolutionizing Federal Procurement
- NeuroOne's Recent Financial Performance and Corporate Developments
- Genius Group’s Innovative Moves: EGM for Share Buyback Decision
- Mangoceuticals Innovates Antiviral Solutions Against Avian Flu
- Oberheiden P.C. Welcomes Michele A. Ratcliffe to Their Team
- Innovative Trends in Smart Food Packaging Leading Market Growth
- Acronis Highlights Growing Cybersecurity Threats in Latest Report
- The Surging Popularity of Organic Rice Syrup in Global Market
- Transforming Luxury Real Estate Investment through Blockchain
- SalMar Schedules Fourth Quarter 2024 Results Presentation
- Ollie's Expands Its Bargain Reach with New Store Openings
- Embraer S.A. Completes Cash Tender Offer for 5.400% Notes
- The Impact of Modern Payment Solutions on Corporate ROI
- Eminent Gold Achieves Strategic Acquisition of Celts Project
- P10 Announces Impressive Earnings for 2024 and 2025 Outlook
- Innovative Collaboration Between AbbVie and Xilio Therapeutics
- Xilio Therapeutics Unveils Advanced T Cell Engager Programs
- Ocugen Reports Successful Completion of Phase 2 Trial for OCU410